Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. NTNX
9. HPQ
10. A

Go back to Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
(NASDAQ: SILO) Delayed: 2.54 +0.04 (1.60%)
Previous Close $2.50    52 Week High $ 
Open $2.44    52 Week Low $ 
Day High $2.57    P/E N/A 
Day Low $2.43    EPS $ 
Volume 17,967       

(NASDAQ: SILO) Delayed: 2.54 +0.04 (1.60%)
Previous Close $2.50    52 Week High $ 
Open $2.44    52 Week Low $ 
Day High $2.57    P/E N/A 
Day Low $2.43    EPS $ 
Volume 17,967